Covered recipient · General Payments record
RUSSELL S DOXEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$825.58
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $488.52 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $100.68 | 4 |
| Astellas Pharma US Inc | $86.71 | 4 |
| GlaxoSmithKline, LLC. | $74.68 | 5 |
| PFIZER INC. | $67.85 | 3 |
| Amgen Inc. | $43.35 | 3 |
| Lilly USA, LLC | $41.78 | 3 |
| DEXCOM, INC. | $22.02 | 1 |
| Janssen Pharmaceuticals, Inc | $14.60 | 1 |
| Novo Nordisk AS | $13.71 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.53 | 1 |
| Organon LLC | $9.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.29 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107040156 | CMS |
| ABBVIE INC. | $32.89 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107040158 | CMS |
| ABBVIE INC. | $33.15 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107040160 | CMS |
| ABBVIE INC. | $19.35 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107040162 | CMS |
| Amgen Inc. | $13.58 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117544340 | CMS |
| Amgen Inc. | $13.24 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117544342 | CMS |
| Amgen Inc. | $16.53 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117241781 | CMS |
| Astellas Pharma US Inc | $18.01 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139494030 | CMS |
| Astellas Pharma US Inc | $18.29 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139520273 | CMS |
| Astellas Pharma US Inc | $32.13 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139532408 | CMS |
| Astellas Pharma US Inc | $18.28 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139517909 | CMS |
| Dexcom, Inc. | $22.02 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384388 | CMS |
| GlaxoSmithKline, LLC. | $13.75 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116405061 | CMS |
| GlaxoSmithKline, LLC. | $15.77 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116316382 | CMS |
| GlaxoSmithKline, LLC. | $13.63 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116301580 | CMS |
| GlaxoSmithKline, LLC. | $14.07 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116257476 | CMS |
| GlaxoSmithKline, LLC. | $17.46 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115759419 | CMS |
| Janssen Pharmaceuticals, Inc | $14.60 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078220627 | CMS |
| Lilly USA, LLC | $13.75 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933944 | CMS |
| Lilly USA, LLC | $13.20 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933946 | CMS |
| Lilly USA, LLC | $14.83 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135955329 | CMS |
| Novo Nordisk Inc | $13.71 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100371984 | CMS |
| Organon Llc | $9.61 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136220629 | CMS |
| PFIZER INC. | $24.36 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131288668 | CMS |
| PFIZER INC. | $20.99 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131893396 | CMS |
| PFIZER INC. | $22.50 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132081764 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.53 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151161878 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.